Latigo Biotherapeutics, Inc. LTGO
Set alert
At close · Oct 30
After hours · Oct 30, 4:05 PM ET
- YTD
- -23.56%
- 1 year
- -23.56%
- Open
- 15.65
- Prev close
- 15.54
- Mkt cap
- 924.88M
- Vol
- 216.17K
- Avg vol
- 340.34K
- EPS
- -2.52
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.66
- High
- 15.70
- Forward P/E
- -7.44
- Beta
- 0.00
- Short ratio
- 1.91
- Inst. own
- 80.73%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 19.18
- 200-d avg
- 19.18
- 1y target
- 52.25
News
-
1 month ago benzinga.com
Latigo Biotherapeutics Q2 EPS $(27.59) Up From $(36.52) YoY, Sales $0.00, Same YoY
Latigo Biotherapeutics (NASDAQ:LTGO) reported quarterly losses of $(27.59) per share. This is a 24.45 percent increase over losses of $(36.52) per share from the same period last year. The company…
-
2 months ago benzinga.com
Leerink Partners Initiates Coverage On Latigo Biotherapeutics with Outperform Rating, Announces Price Target of $36
Leerink Partners analyst David Risinger initiates coverage on Latigo Biotherapeutics (NASDAQ:LTGO) with a Outperform rating and announces Price Target of $36.
-
2 months ago benzinga.com
Jefferies Initiates Coverage On Latigo Biotherapeutics with Buy Rating, Announces Price Target of $50
Jefferies analyst Akash Tewari initiates coverage on Latigo Biotherapeutics (NASDAQ:LTGO) with a Buy rating and announces Price Target of $50.
-
2 months ago benzinga.com
Guggenheim Initiates Coverage On Latigo Biotherapeutics with Buy Rating, Announces Price Target of $50
Guggenheim analyst Yatin Suneja initiates coverage on Latigo Biotherapeutics (NASDAQ:LTGO) with a Buy rating and announces Price Target of $50.
-
3 months ago benzinga.com
Reported Earlier, Latigo Biotherapeutics Files To Sell Up To 16M IPO Shares Priced At $16-$18 Per Share
This is an initial public offering of shares of common stock of Latigo Biotherapeutics, Inc. We are offering 16,000,000 shares of our common stock to be sold in this offering.Prior to this offering,…